Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patientsMazzaschi, G. ; Cardinale, E. ; Pluchino, M. ; Monica, G. ; Lorusso, B. ; D'Agnelli, S. ; Trentini, F. ; Tamarozzi, P. ; Dalla Tor, L. Moron ; Verzè, M. ; Minari, R. ; Bordi, P. ; Perrone, F. ; Leonetti, A. ; Gnetti, L. ; Roti, G. ; Quaini, F. ; Sverzellati, N. ; Tiseo, M.Annals of oncology, 2023-10, Vol.34, p.S1183-S1183 [Periódico revisado por pares]Elsevier LtdSem texto completo |
2 |
Material Type: Artigo
|
![]() |
9P Identification of a μCT-based radiomic signature of CD8+ tumour infiltrating lymphocytes in an orthotopic murine modelMazzaschi, G. ; Dos Santos, M. ; Bergeron, P. ; Sitterle, L. ; Gérbé de Thoré, M. ; Liu, W. ; Clémenson, C. ; Meziani, L. ; Bawa, O. ; Leroy, A. ; Sun, R. ; Moron Dalla Tor, L. ; Quaini, F. ; Tiseo, M. ; Milliat, F. ; Robert, C. ; Mondini, M. ; Deutsch, E.Annals of oncology, 2023-10, Vol.34, p.S189-S189 [Periódico revisado por pares]Elsevier LtdSem texto completo |
3 |
Material Type: Artigo
|
![]() |
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patientsMazzaschi, G. ; Milanese, G. ; Moron Dalla Tor, L. ; Leo, L. ; Balbi, M. ; Trentini, F. ; Manini, M. ; Pavone, C. ; Silva, M. ; Ledda, R.E. ; Minari, R. ; Bordi, P. ; Buti, S. ; Leonetti, A. ; Roti, G. ; Quaini, F. ; Sverzellati, N. ; Tiseo, M.Annals of oncology, 2021-12, Vol.32, p.S1380-S1381 [Periódico revisado por pares]Texto completo disponível |
4 |
Material Type: Artigo
|
![]() |
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLCMazzaschi, G. ; Moron Dalla Tor, L. ; Balbi, M. ; Milanese, G. ; Tognazzi, D. ; Lorusso, B. ; Trentini, F. ; Di Rienzo, G. ; Verzè, M. ; Pluchino, M. ; Minari, R. ; Leo, L. ; Gnetti, L. ; Bordi, P. ; Leonetti, A. ; Ampollini, L. ; Roti, G. ; Quaini, F. ; Sverzellati, N. ; Tiseo, M.Annals of oncology, 2022-09, Vol.33, p.S1039 [Periódico revisado por pares]Texto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiationdel Carpio, L.P. ; Gomila, P. ; Camacho, S.D. ; Moron, S. ; Riudavets, M. ; Molto, C. ; Bujosa, A. ; Borrell, M. ; Teres, R. ; Martin, B. ; Gallardo, P. ; Acosta, E. ; Tilea, L. ; Soto, A. ; De Quintana, C. ; Craven-Bartle, J. ; Gallardo, A. ; Gomez, B. ; Bonilla, S. ; Gallego, O.Annals of oncology, 2018-10, Vol.29, p.viii127-viii127 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)Riudavets Melia, M. ; Gabriela Sullivan, I. ; Barba Joaquín, A. ; Anguera Palacios, G. ; del Carpio, L.P. ; Molto Valiente, C. ; Camacho Arellano, S.D. ; Moron Asensio, S. ; Gomila Pons, P. ; Andres Granyó, M. ; Castillo Villegas, D. ; Facundo Molas, C. ; Garcia Planella, E. ; González Blanco, C. ; Barnadas Molins, A. ; Gich Saladich, I. ; Majem Tarruella, M.Annals of oncology, 2018-10, Vol.29, p.viii509-viii509 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
2044P Bloodstream infections (BSI) in cancer patients: Epidemiology, antibiotic therapy and risk factors related to mortalityJiménez, C. López ; Lozano, R. Martín ; Rodríguez, R. Jiménez ; Caraballo, I. Gonzalez ; Benavente, M. ; Ortiz, A. Gutierrez ; Caamaño, D.S. Juliao ; Alonso, N. Gutierrez ; Alsar, J. Soto ; Beranek, M. Bringas ; Palma, M. ; Cañete Muñoz, M.A. ; Biscari, L. ; Martin-Nieto, P. ; Morón, B.I. ; Anula, V.C. Tirado ; De Toro Carmena, M.T. ; Valles, M. Arregui ; Vidaurreta, P. GijónAnnals of oncology, 2023-10, Vol.34, p.S1083-S1083 [Periódico revisado por pares]Elsevier LtdSem texto completo |
8 |
Material Type: Artigo
|
![]() |
2146P Cancer-associated thrombosis clinic: Experience of the Medical Oncology Department of a hospital in SpainMorán, L. Ortega ; Alsar, J. Soto ; Rodríguez, R. Jiménez ; Jiménez, C. López ; Ortiz, A. Gutierrez ; Caamaño, D.S. Juliao ; Lozano, R. Martín ; Caraballo, I. Gonzalez ; Palma, M. ; Cañete Muñoz, M.A. ; Benavente, M. ; García, B. Morón ; Perez-Solero, G. Torres ; Jimenez, M. Martin ; Martin, A.J. MunozAnnals of oncology, 2023-10, Vol.34, p.S1117-S1118 [Periódico revisado por pares]Elsevier LtdSem texto completo |
9 |
Material Type: Artigo
|
![]() |
1654P Circulating tumor cells (CTCs) as prognostic factor for pancreatic cancer: Updated of a prospective studyGutierrez Alonso, N. ; Benavente, M. ; Bringas Beranek, M. ; Soto Alsar, J. ; Palma, M. ; Cañete Muñoz, M.A. ; Lopez Alfonso, A. ; Rahimi Mousavi, P. ; Roche-Molina, M. ; Del Monte-Millan, M. ; Megias, D. ; García Pérez, Á. ; Mullor Delgado, L.A. ; Ortega Morán, L. ; Torres Perez-Solero, G. ; Morón, B.I. ; Calvo Ferrandiz, P.A. ; García Alfonso, P. ; Martin Jimenez, M. ; Munoz Martin, A.J.Annals of oncology, 2023-10, Vol.34, p.S912-S912 [Periódico revisado por pares]Elsevier LtdSem texto completo |
10 |
Material Type: Artigo
|
![]() |
Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)Moreno, V. ; Gil-Martin, M. ; Johnson, M. ; Aljumaily, R. ; Lopez Criado, P. ; Northfelt, D.W. ; Crittenden, M. ; Jabbour, S. ; Rosen, L. ; Garrido Lopez, P. ; Hervás Morón, A. ; Rietschel, P. ; Mohan, K.K. ; Li, J. ; Stankevich, E. ; Rowlands, T. ; Feng, M. ; Lowy, I. ; Fury, M.G.Annals of oncology, 2018-10, Vol.29, p.viii414-viii414 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |